Bodenstedt Matthias 4
4 · MoonLake Immunotherapeutics · Filed Dec 21, 2023
Insider Transaction Report
Form 4
Bodenstedt Matthias
Chief Financial Officer
Transactions
- Sale
Class A ordinary shares, par value $0.0001 per share
2023-12-19$59.22/sh−94,736$5,610,266→ 526,167 total - Sale
Class A ordinary shares, par value $0.0001 per share
2023-12-20$58.34/sh−5,264$307,102→ 520,903 total
Footnotes (3)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2023.
- [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $56.655 to $60.13. Upon request by the staff of the U.S. Securities and Exchange Commission (the "Commission"), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $57.53 to $59.27. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.